CoChat

Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms

Li, Fei, Zheng, Zaosong, Chen, Wei, Li, Dongqing, Zhang, Henghui, Zhu, Yuanchao, Mo, Qixin, Zhao, Xinlei, Fan, Qin, Deng, Fan, Han, Conghui, Tan, Wanlong · 2023 · Drug Resistance Updates
Cited by 211

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Bladder cancer is one of the most common malignancies in the world. Cisplatin is one of the most potent and widely used anticancer drugs and has been employed in several malignancies. Cisplatin-based combination chemotherapies have become important adjuvant therapies for bladder cancer patients. Cisplatin-based treatment often results in the development of chemoresistance, leading to therapeutic failure and limiting its application and effectiveness in bladder cancer. To develop improved and more effective cancer therapy, research has been conducted to elucidate the underlying mechanism of cisplatin resistance. Epigenetic modifications have been demonstrated involved in drug resistance to chemotherapy, and epigenetic biomarkers, such as urine tumor DNA methylation assay, have been applied in patients screening or monitoring. Here, we provide a systematic description of epigenetic mechanisms, including DNA methylation, noncoding RNA regulation, m6A modification and posttranslational modifications, related to cisplatin resistance in bladder cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drup.2023.100938

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 211

Metadata

Authors
Li, F., Zheng, Z., Chen, W., Li, D., Zhang, H., Zhu, Y., Mo, Q., Zhao, X., Fan, Q., Deng, F., Han, C., & Tan, W.
Venue
Drug Resistance Updates
Publisher
Elsevier BV
Published
2023-05
Volume
68
Pages
100938
ISSN
1368-7646 (ISSN-L)
OpenAlex
W4319767189
Cited by
211
References
7
FWCI
16.74
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. https://app.cochat.ai/papers/10.1016/j.drup.2023.100938
The paper
Li, F., Zheng, Z., Chen, W., Li, D., Zhang, H., Zhu, Y., Mo, Q., Zhao, X., Fan, Q., Deng, F., Han, C., & Tan, W. (2023). Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2023.100938

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.